An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
Active, not recruiting · NCT06335979 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Active, not recruiting | Phase 1 | 2026-06-30 | NCT06335979 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||